US Patent Issued to JAPANESE FOUNDATION FOR CANCER RESEARCH on May 19 for "Test method of dividing blastic plasmacytoid dendritic cell neoplasm (BPDCN) into subtypes" (Japanese Inventors)

ALEXANDRIA, Va., May 19 -- United States Patent no. 12,630,883, issued on May 19, was assigned to JAPANESE FOUNDATION FOR CANCER RESEARCH (Tokyo).

"Test method of dividing blastic plasmacytoid dendritic cell neoplasm (BPDCN) into subtypes" was invented by Kengo Takeuchi (Tokyo), Kana Sakamoto (Tokyo), Ryohei Katayama (Tokyo) and Seiji Sakata (Tokyo).

According to the abstract* released by the U.S. Patent & Trademark Office: "The diagnostic markers that provide novel diagnostic criteria to blastic plasmacytoid dendritic cell neoplasm (BPDCN) has been searched, and the presence of immunoblastoid cytomorphology, 8q24 rearrangement, and MYC expression were established as novel markers for subtyping BPDCN. It has been further found that the in...